Thyroxine (T4 / FT4)

Clinical interpretation, reference ranges, and thyroid status evaluation for Thyroxine (T4/FT4) under ATA 2017 standards.

Editorial review complete

Independent clinical validation is pending.

Validation pending

Quick Reference Facts

Specimen TypeVenous Blood (Serum)
PreparationFasting optional unless ordered with lipid panel
Turnaround Time24–48 Hours
Clinical CategoryThyroid

Laboratory Interpretation Workflow

Stage 1 of 5

1. Clinical Indication

Ordering protocols based on clinical indications, presenting symptoms, or screening guidelines.

Clinical Pearl: Order when screening for primary organ dysfunctions or monitoring active treatment efficacy.

Test Description & Overview

Thyroxine (T4): The primary prohormone synthesized and secreted by the thyroid gland follicular cells, circulating mostly bound to thyroxine-binding globulin (TBG). Free T4 (FT4) represents the metabolically active, unbound fraction (0.03%).

Standard Reference Range

Free T4 (FT4): 0.8 - 1.8 ng/dL (10 - 23 pmol/L); Total T4: 4.5 - 11.2 mcg/dL (58 - 144 nmol/L).

Elevated (High) Values

  • Primary Hyperthyroidism (Graves' Disease, Toxic Nodular Goiter)
  • Subacute Granulomatous (de Quervain's) Thyroiditis (Release Phase)
  • Exogenous Levothyroxine Overdose or Pituitary TSH-Secreting Adenoma

Decreased (Low) Values

  • Primary Hypothyroidism (Hashimoto's Thyroiditis, Post-Ablation)
  • Secondary / Central Hypothyroidism (Pituitary or Hypothalamic Failure)
  • Severe Myxedema Coma (Profound Low FT4 with Hypothermia and Altered Sensorium)

Clinical Alignment & Significance

Free T4 (FT4) combined with TSH is the primary diagnostic pair for thyroid disease; low FT4 with elevated TSH confirms primary hypothyroidism, while low FT4 with low/normal TSH indicates central hypothyroidism requiring pituitary imaging.

Diagnostic Guidance Notice

Standard laboratory reference ranges vary based on the testing facility. Significant deviations require immediate clinician review to rule out severe medical pathology.

Reference Citations & Evidence Sources

Clinical Guidelines & Consensus Statements
  • CIT-0068Alexander E. K., Pearce E. N., Brent G. A.. "2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum." Thyroid (2017).DOI PubMed
Clinical Reviews & Textbooks
  • CIT-0023National Center for Complementary and Integrative Health. "Homeopathy: What You Need To Know." National Institutes of Health (2021).

AI & Generative Search Citation Block

Entity IDL0011
Entity Typelab-test
Content Versionv1.1.0
Last Reviewed DateJul 31, 2026
Evidence LevelTraditional-Literature
Suggested Academic/LLM Citation format (AMA Style)

Dr. Narayan Jethwani. "Thyroxine (T4 / FT4)." Homeo Healthcare Clinical Platform. Version 1.1.0. Reviewed: 2026-07-31T19:50:00Z. Available at: https://homeo.healthcare/knowledge/lab-tests/t4

No clinical connections registered for this topic.

Medical Safety Disclaimer

All content on the Homeo Healthcare platform is strictly for educational purposes and is not personal medical advice, diagnosis, or treatment. Homeopathic remedy considerations are provided for clinician review or require individualized consultation with a qualified physician. Never delay seeking professional medical advice or emergency medical care due to content you have read on this website.